Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BZCIJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DAC-002
|
|||||
| Synonyms |
DAC 002; DAC-002/JS108; JS 108; JS-108; TUB-196; humanized anti-TROP2 mAb-Tub196 conjugate
Click to Show/Hide
|
|||||
| Organization |
Hangzhou DAC Biotech Co., Ltd.; Shanghai Junshi Biosciences Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 2 Indication(s)
Small cell lung cancer [ICD11:2C25]
Phase 1
Triple negative breast cancer [ICD11:2C60-2C65]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.